SCHEMBL24328857

SCHEMBL24328857

CO[C@H](C(=O)O)c1ccccn1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.47
CYP1A2 P05177 2/20 0.47
TSHR P16473 4/20 0.45
CYP3A4 P08684 3/20 0.45
KDM4E B2RXH2 3/20 0.45
LMNA P02545 3/20 0.45
SLC6A3 Q01959 2/20 0.45
ABCB11 O95342 1/20 0.45
ESR1 P03372 1/20 0.45
ADRA2A P08913 1/20 0.45
CYP2C9 P11712 1/20 0.45
PDE4A P27815 1/20 0.45
ADRA1A P35348 1/20 0.45
OPRK1 P41145 1/20 0.45
STAT6 P42226 1/20 0.45
HIF1A Q16665 1/20 0.45
GPR55 Q9Y2T6 1/20 0.45
MEN1 O00255 1/20 0.44
GAA P10253 1/20 0.44
KMT2A Q03164 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5040505 1.00 ALDH1A1 (0.47) ALDH1A1CYP1A2TSHRCYP3A4KDM4E
SCHEMBL24327755 1.00 ALDH1A1 (0.47) ALDH1A1CYP1A2TSHRCYP3A4KDM4E
SCHEMBL15743150 0.87 CYP3A4 (0.44) ALDH1A1CYP1A2TSHRCYP3A4KDM4E
SCHEMBL11710727 0.84 TSHR (0.44) ALDH1A1CYP1A2TSHRCYP3A4KDM4E
SCHEMBL11713277 0.84 KMT2A (0.47) ALDH1A1CYP1A2TSHRCYP3A4KDM4E
Hydrochloric Acid SCHEMBL11713887 0.83 CYP3A4 (0.46) ALDH1A1CYP1A2TSHRCYP3A4KDM4E
SCHEMBL27503970 0.81 ALDH1A1 (0.51) ALDH1A1CYP1A2TSHRCYP3A4KDM4E
SCHEMBL11716870 0.81 TSHR (0.44) ALDH1A1CYP1A2TSHRCYP3A4KDM4E
SCHEMBL11063759 0.81 KDM4E (0.44) ALDH1A1CYP1A2TSHRCYP3A4KDM4E
Maleic Acid SCHEMBL11714632 0.78 ALDH1A1 (0.47) ALDH1A1CYP1A2TSHRCYP3A4KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230399297-A1 Novel Glutamine Analogs JACOBIO PHARMACEUTICALS CO., LTD (CN) 2023-12-14 US disclosed
WO-2022078416-A1 NOVEL GLUTAMINE ANALOGS JACOBIO PHARMACEUTICALS CO., LTD. (CN) 2022-04-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230399297-A1 Novel Glutamine Analogs GLUL, GATD3, GLS ALDH1A1 4320/4885CYP1A2 4385/4885TSHR 3476/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.